COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
|
作者：
TIDEFELT, U
SUNDMANENGBERG, B
PAUL, C
机构：
[1] HUDDINGE HOSP,DEPT MED,DIV CLIN HEMATOL & ONCOL,S-14146 HUDDINGE,SWEDEN
[2] KAROLINSKA INST,S-14186 HUDDINGE,SWEDEN
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225 / 229
页数：5
相关论文
共 50 条
  • [41] RANDOMIZED TRIAL COMPARING COMBINATIONS OF CYCLOPHOSPHAMIDE AND CISPLATIN WITHOUT OR WITH DOXORUBICIN OR 4'-EPI-DOXORUBICIN IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
    HERNADI, Z
    JUHASZ, B
    POKA, R
    LAMPE, LG
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1988, 27 (02) : 199 - 204
  • [42] RELATIONSHIP BETWEEN THE EFFECT ON CALCIUM TURNOVER AND EARLY CARDIOTOXICITY OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN GUINEA-PIG HEART-MUSCLE
    VILLANI, F
    FAVALLI, L
    PICCININI, F
    TUMORI, 1980, 66 (06) : 689 - 697
  • [43] A PHASE-II CLINICAL-TRIAL OF 4'-EPI-DOXORUBICIN IN ADVANCED SOLID TUMORS
    MARTONI, A
    GIOVANNINI, M
    TOMASI, L
    CAMAGGI, CM
    BELLANOVA, B
    MONETTI, N
    ROSSINI, G
    TARQUINII, M
    MARTINI, A
    PANNUTI, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (03) : 179 - 182
  • [44] PHASE-II CLINICAL-TRIAL OF 4'-EPI-DOXORUBICIN IN METASTATIC SOLID TUMORS
    KOLARIC, K
    POTREBICA, V
    CERVEK, J
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 106 (02) : 148 - 152
  • [45] ACUTE-LEUKEMIA IN PREGNANCY - SUCCESSFUL DELIVERY AFTER CYTARABINE AND DOXORUBICIN
    NEWCOMB, M
    BALDUCCI, L
    THIGPEN, JT
    MORRISON, FS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 239 (25): : 2691 - 2692
  • [46] PHARMACOKINETIC STUDIES OF 4'-EPI-DOXORUBICIN IN CANCER-PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION AND WITH HEPATIC METASTASES
    CAMAGGI, CM
    STROCCHI, E
    TAMASSIA, V
    MARTONI, A
    GIOVANNINI, M
    IAFELICE, G
    CANOVA, N
    MARRARO, D
    MARTINI, A
    PANNUTI, F
    CANCER TREATMENT REPORTS, 1982, 66 (10): : 1819 - 1824
  • [47] PHASE-II TRIAL OF 4'-EPI-DOXORUBICIN IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER
    KALMAN, LA
    KRIS, MG
    GRALLA, RJ
    KELSEN, DP
    CASPER, ES
    HEELAN, RT
    WITTES, RE
    CANCER TREATMENT REPORTS, 1983, 67 (06): : 591 - 592
  • [48] A RANDOMIZED COMPARISON OF DOXORUBICIN AND DOXORUBICIN-DNA IN THE TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA
    PAUL, C
    TIDEFELT, U
    GAHRTON, G
    BJORKHOLM, M
    JARNMARK, M
    KILLANDER, A
    KIMBY, E
    LILIEMARK, J
    LINDEBERG, A
    LINDQUIST, R
    LOCKNER, D
    LONNQVIST, B
    MELLSTEDT, H
    MERK, K
    PALMBLAD, J
    PETERSON, C
    SIMONSSON, B
    STALFELT, AM
    SUNDSTROM, C
    WADMAN, B
    WEDELIN, C
    UDEN, AM
    OBERG, G
    OST, A
    LEUKEMIA & LYMPHOMA, 1991, 3 (5-6) : 355 - 364
  • [49] PHASE-II TRIAL OF 4'-EPI-DOXORUBICIN IN ADVANCED-CARCINOMA OF HEAD AND NECK ORIGIN
    MAGEE, MJ
    HOWARD, J
    BOSL, GJ
    WITTES, RE
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 125 - 126
  • [50] PHASE-II TRIAL OF 4'-EPI-DOXORUBICIN IN LOCALLY ADVANCED OR METASTATIC GASTRIC-CANCER
    CAZAP, E
    ESTEVEZ, R
    BRUNO, M
    LEVY, D
    ALGAMIZ, C
    CHACON, R
    BADANO, C
    ROMERO, A
    DESIMONE, G
    ROCA, E
    ARTEAGA, C
    HANNOIS, A
    KOTLIAR, M
    WOOLEY, P
    TUMORI JOURNAL, 1988, 74 (03): : 313 - 315
12345